Your browser doesn't support javascript.
Understanding COVID-19: From Dysregulated Immunity to Vaccination Status Quo.
Escobedo, Ruby A; Singh, Dhiraj K; Kaushal, Deepak.
  • Escobedo RA; Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, United States.
  • Singh DK; The Integrated Biomedical Sciences (IBMS) Graduate Program, University of Texas Health Sciences Center at San Antonio, San Antonio, TX, United States.
  • Kaushal D; Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, United States.
Front Immunol ; 12: 765349, 2021.
Article in English | MEDLINE | ID: covidwho-1551508
ABSTRACT
The development of vaccines against infectious diseases has helped us battle the greatest threat to public health. With the emergence of novel viruses, targeted immunotherapeutics ranging from informed vaccine development to personalized medicine may be the very thing that separates us between life and death. Late in 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent of coronavirus disease 2019 (COVID-19), made a remarkable entrance to human civilization, being one of many to cross the species barrier. This review discusses the important aspects of COVID-19, providing a brief overview of our current understanding of dysregulated immune responses developed using various experimental models, a brief outline of experimental models of COVID-19 and more importantly, the rapid development of vaccines against COVID-19.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Etiology study / Randomized controlled trials Topics: Vaccines Limits: Animals / Humans Language: English Journal: Front Immunol Year: 2021 Document Type: Article Affiliation country: Fimmu.2021.765349

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Etiology study / Randomized controlled trials Topics: Vaccines Limits: Animals / Humans Language: English Journal: Front Immunol Year: 2021 Document Type: Article Affiliation country: Fimmu.2021.765349